The synthesis of Gemcitabine, a potent antineoplastic agent, relies heavily on the availability of high-quality intermediates. Among these, 2-deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate, identified by CAS number 122111-01-7, stands out as a crucial building block. At NINGBO INNO PHARMCHEM CO.,LTD., we are a dedicated manufacturer and supplier committed to providing pharmaceutical companies with this essential compound, ensuring the seamless production of Gemcitabine.

Our expertise in producing complex organic molecules allows us to offer 2-deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate with exceptional purity, a critical factor for pharmaceutical applications. For R&D scientists and procurement managers looking to buy Gemcitabine intermediate, understanding the specifications and reliability of the supplier is paramount. We provide detailed product information, including its characteristic white to off-white solid appearance and a guaranteed purity of 98.5%, which is vital for efficient and successful synthesis.

As a leading pharmaceutical intermediate supplier in China, we understand the importance of a stable supply chain. We cater to both research laboratories requiring smaller quantities and large-scale manufacturers needing bulk supplies. Our proactive approach to inventory management and production planning ensures that our clients can always rely on us for their sourcing needs. If you are seeking a reliable partner to purchase CAS 122111-01-7, look no further. We offer competitive pricing and are ready to provide detailed quotes upon request.

The pharmaceutical industry demands precision and adherence to strict quality standards. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to meeting these demands by consistently delivering high-grade intermediates. By choosing us as your Gemcitabine intermediate manufacturer, you gain access to a trusted source that prioritizes product integrity and customer satisfaction. We invite you to connect with us to discuss your specific requirements and how we can support your ongoing pharmaceutical development and manufacturing projects.